Home Cart Sign in  
Chemical Structure| 68359-07-9 Chemical Structure| 68359-07-9

Structure of 68359-07-9

Chemical Structure| 68359-07-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 68359-07-9 ]

CAS No. :68359-07-9
Formula : C8H8ClNO3
M.W : 201.61
SMILES Code : CCOC1=NC=C(Cl)C=C1C(O)=O
MDL No. :MFCD07403147
InChI Key :DTIBPOFHVJBUSH-UHFFFAOYSA-N
Pubchem ID :5311904

Safety of [ 68359-07-9 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 68359-07-9 ] Show Less

Physicochemical Properties

Num. heavy atoms 13
Num. arom. heavy atoms 6
Fraction Csp3 0.25
Num. rotatable bonds 3
Num. H-bond acceptors 4.0
Num. H-bond donors 1.0
Molar Refractivity 47.51
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

59.42 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.73
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

1.68
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

1.83
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-0.04
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

1.7
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

1.38

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-2.29
Solubility 1.03 mg/ml ; 0.00511 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.54
Solubility 0.578 mg/ml ; 0.00287 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-2.55
Solubility 0.566 mg/ml ; 0.00281 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.34 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

0.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.56

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.97

Application In Synthesis of [ 68359-07-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 68359-07-9 ]

[ 68359-07-9 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 35969-54-1 ]
  • [ 68359-07-9 ]
References: [1] Synthetic Communications, 1989, vol. 19, # 9-10, p. 1505 - 1508.
  • 2
  • [ 2942-59-8 ]
  • [ 68359-07-9 ]
References: [1] Synthetic Communications, 1989, vol. 19, # 9-10, p. 1505 - 1508.
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 68359-07-9 ]

Chlorides

Chemical Structure| 22620-27-5

A213623 [22620-27-5]

5-Chloronicotinic acid

Similarity: 0.81

Chemical Structure| 88912-22-5

A217075 [88912-22-5]

5-Chloro-2-methoxyisonicotinic acid

Similarity: 0.77

Chemical Structure| 58498-61-6

A222565 [58498-61-6]

5-Chloro-3-methylpyridin-2-ol

Similarity: 0.73

Chemical Structure| 13473-01-3

A384962 [13473-01-3]

5-Chloro-2-methoxypyridine

Similarity: 0.73

Chemical Structure| 52833-93-9

A215720 [52833-93-9]

2-Amino-5-chloropyridine-3-carboxylic acid

Similarity: 0.73

Ethers

Chemical Structure| 88912-22-5

A217075 [88912-22-5]

5-Chloro-2-methoxyisonicotinic acid

Similarity: 0.77

Chemical Structure| 1221171-92-1

A375137 [1221171-92-1]

2-(Trifluoromethoxy)pyridine-3-carboxylic acid

Similarity: 0.74

Chemical Structure| 13473-01-3

A384962 [13473-01-3]

5-Chloro-2-methoxypyridine

Similarity: 0.73

Chemical Structure| 16727-43-8

A185410 [16727-43-8]

2,6-Dimethoxynicotinic acid

Similarity: 0.72

Chemical Structure| 112197-16-7

A198472 [112197-16-7]

(2-Methoxypyridin-3-yl)methanol

Similarity: 0.72

Carboxylic Acids

Chemical Structure| 22620-27-5

A213623 [22620-27-5]

5-Chloronicotinic acid

Similarity: 0.81

Chemical Structure| 88912-22-5

A217075 [88912-22-5]

5-Chloro-2-methoxyisonicotinic acid

Similarity: 0.77

Chemical Structure| 1221171-92-1

A375137 [1221171-92-1]

2-(Trifluoromethoxy)pyridine-3-carboxylic acid

Similarity: 0.74

Chemical Structure| 52833-93-9

A215720 [52833-93-9]

2-Amino-5-chloropyridine-3-carboxylic acid

Similarity: 0.73

Chemical Structure| 16727-43-8

A185410 [16727-43-8]

2,6-Dimethoxynicotinic acid

Similarity: 0.72

Related Parent Nucleus of
[ 68359-07-9 ]

Pyridines

Chemical Structure| 22620-27-5

A213623 [22620-27-5]

5-Chloronicotinic acid

Similarity: 0.81

Chemical Structure| 88912-22-5

A217075 [88912-22-5]

5-Chloro-2-methoxyisonicotinic acid

Similarity: 0.77

Chemical Structure| 1221171-92-1

A375137 [1221171-92-1]

2-(Trifluoromethoxy)pyridine-3-carboxylic acid

Similarity: 0.74

Chemical Structure| 58498-61-6

A222565 [58498-61-6]

5-Chloro-3-methylpyridin-2-ol

Similarity: 0.73

Chemical Structure| 13473-01-3

A384962 [13473-01-3]

5-Chloro-2-methoxypyridine

Similarity: 0.73